Clinical Trials Sponsored by William R. Drobyski, MD
Total 1 results
-
William R. Drobyski, MDCompletedHematopoietic Stem Cell TransplantationUnited States
Sponsors and Collaborators
- Mahmoud Awad Ramadan Elkholy
- Asia-Pacific Hepatocellular Carcinoma (AHCC) Trials Group
- Dawn Brewer
- Spineology, Inc
- University Düsseldorf
- Conselleria de Innovación, Universidades, Ciencia y Sociedad Digital.
- Atlanta Pediatric Device Consortium
- Catholic University of Health and Allied Sciences
- Beijing Arion Cancer Center
- Grant from "Axiomedic. Advanced Medical Solutions", Zurich, Switzerland
- French Society for Intensive Care
- Inozyme Pharma
- AFC (Association Francophone de Chirurgie)
- Intersci Research Association, Austria
- Bone Cancer Research Trust
- Stadt Homburg
- Dutch Transplantation Fund
- charbel najem
- William R. Drobyski, MD
- Yao Xie
- View Full List
Medical Conditions
- Allergic Conjunctivitis Due to Dermatophagoides Pteronyssinus
- Diabetes Type I
- Demyelination; Corpus Callosum
- Pseudo Exfoliative Syndrome
- Prognostic Stage I Breast Cancer AJCC v8
- Deficient Keratinized Mucosa
- Squamous Cell Carcinomas of the Head and Neck
- Polypectomy
- Neoadjuvant Non-Small Cell Lung Cancer
- Atrophic Nonunion of Fracture
- Paracetamol Toxicity
- Progesteron
- Allergic Diseases
- HIV Risk
- Postmenopause
- Lower Limb Arterial Disease
- Efficacy of Trishul
- Dental Pain and Sensation Disorder
- Traditional Rehabilitation After ACL Reconstruction Vs Training Vs Traditional Rehabilitation Plus Inertial Exercises
- Conflict Resolution Styles
- View Full List
Drug Interventions
- Lecitone®Se-Vitamin D3
- Control group
- Vitamin B12
- Aloe vera gel
- Nab-paclitaxel
- Nirmatrelvir/Ritonavir
- Melatonin 20 MG
- Serdolect
- Zanubrutinib
- BIIF 1149 BS
- Ferric derisomaltose
- Pregabalin immediate release, 25 mg
- Doxorubicin, Paclitaxel, Cisplatin
- S-2367 1600 mg
- Nigella sativa seeds extract containing ointment intervention
- Enoxaparin, Heparin
- Alphagan
- Sequence 2 : Period 1 (VR 160/20 mg-2), Period 2 (V+R), Period 3 (VR 160/20 mg-1)
- CKD-498 dose#2
- PA9159 Metered-Dose Inhaler, 240 μg per day for 28 days
- View Full List
CROs by country
- Contract Research Organizations in Bahamas
- Contract Research Organizations in Belarus
- Contract Research Organizations in Bulgaria
- Contract Research Organizations in Cote d'Ivoire
- Contract Research Organizations in Djibouti
- Contract Research Organizations in Dominican Republic
- Contract Research Organizations in Ethiopia
- Contract Research Organizations in France
- Contract Research Organizations in Indonesia
- Contract Research Organizations in Lithuania
- Contract Research Organizations in Senegal
- Contract Research Organizations in United Kingdom
- Contract Research Organizations in Uzbekistan
- CRO list by country